InvestorsHub Logo
Followers 30
Posts 2489
Boards Moderated 0
Alias Born 05/03/2012

Re: Biobillionair post# 334656

Monday, 04/12/2021 7:24:56 PM

Monday, April 12, 2021 7:24:56 PM

Post# of 430192
If your the Hikma CEO you have to be so pissed right now.....

He gets the biggest gift ever using dirty tactics in Nevada, crows to the investment community how much of their swill they will be able to sell and suddenly hits a wall.

Supply constraints and the difficulty in manufacturing puts a stop to grabbing all the RIT scripts at launch. Next, the Delaware suit drives the two largest insurers to basically block any GV scripts. Now he faces some real damages from their lackluster sales if any of the following occur...

1) Rule 60 win
2) Scotus win and here I would say if Scotus takes the case its a win
3) GSK prevails over Teva makes Delaware even more promising

They are really screwed if one or two happens and somewhat in 3. In any case, 1,2 or 3 was not worth it for Hikma. Vascepa may actually cause heart burn for Hikma... Hope this is the lesson that cheaters should never prosper!


Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News